Neurofit at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Neurofit brings 3 presentations to SfN 2026 in Washington, and exhibits at Booth 936. Its presentations centre on drug effects and cognitive impairment in preclinical models of schizophrenia, anxiety and neuroinflammation. One study examines how semaglutide affects neuroinflammation and memory deficits through a glia-dependent mechanism.

OrganizationSfN 2026 Attendance
Neurofit
Illkirch, France
neurofit.com
Contract research and service companies
French preclinical CRO evaluating drug candidates in in vitro and in vivo models of brain, spinal cord and nerve disorders.
Booth
Exhibiting at Booth 936
Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm
Poster
Sat Nov 14
1–5pm
Poster
Mon Nov 16
1–5pm
Poster
Wed Nov 18
8am–noon

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Neurofit

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction